Dr. Carl J. Rossi Jr., MD

Dr. Rossi practices at Proton Doctors Professional Corporation in San Diego, California.

Dr. Rossi's NPI, 1518983055, was assigned on July 15, 2006. Dr. Rossi graduated from Loyola University Chicago Stritch School of Medicine in 1988. Dr. Rossi holds California license G66352.

Dr. Rossi's primary practice is Proton Doctors Professional Corporation, at 9710 Summers Ridge Rd, San Diego, CA 92121 in San Diego County. The practice phone is (858) 549-7400.

Dr. Rossi's primary practice is Proton Doctors Professional Corporation in San Diego, California. Dr. Rossi is also affiliated with Hillcrest Medical Center. The medical group on file is Proton Doctors PC. Dmand AI also links Dr. Rossi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rossi practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Rossi's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Rossi is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Rossi's licenses on file in 2 states: California and Florida.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation and prostate cancer radiation among the conditions Dr. Rossi treats.

CMS data shows 2,749 Medicare services from Dr. Rossi across 17 procedure codes in 2024, for 311 Medicare patients. Medicare paid $985,676 for them. Every service was in an office.

CMS counts 311 Medicare patients who saw Dr. Rossi in 2024. The largest group is 65 to 74, with 168 patients. 75% of them have cancer, and 65% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rossi's median patient age at 69, with 22% women.

In 2024, Dr. Rossi wrote 99 Medicare Part D claims for 45 patients. 98% of them were for generic drugs. CMS names the drug for 77 of them, across 1 drug with 11 or more claims each, at $931 in total drug cost. In 2023, CMS named 87 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Dr. Rossi for performance year 2024, reported as part of a group. Dr. Rossi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rossi as offering telehealth.

Dmand AI links 30 papers to Dr. Rossi, published from 2006 to 2024. 2019 was the busiest year, with 4. The most frequent topics are Prostatic Neoplasms, Proton Therapy and Radiotherapy Dosage. Dr. Rossi has published most often in Int J Radiat Oncol Biol Phys. Dr. Rossi's most frequent co-authors are Jerry D. Slater, MD, Henry K. Tsai, MD and Carlos E. Vargas, MD.

Dmand AI links Dr. Rossi to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases. Proton Collaborative Group sponsors the most, 2.

CMS Open Payments shows 90 general payments to Dr. Rossi from 16 drug and device companies from 2016 to 2024. Travel and lodging make up the largest share, 68% of the total. Varian Medical Systems, Inc. paid the most, $63,738.

Dmand AI lists 4 awards for Dr. Rossi, most recently America's Top Doctors in 2014.

Dr. Rossi graduated from Loyola University Chicago Stritch School of Medicine in 1988.

Dr. Rossi is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.